MedPath
NMPA Approval

Glucagon Nasal Powder

国药准字HJ20240036

June 4, 2024

Drug Information

高血糖素鼻用粉雾剂

鼻用制剂

3mg

化学药品

June 4, 2024

June 3, 2029

Company Information

Applicant Company

11570 6th Street, Rancho Cucamonga, CA 91730 United States of America

Manufacturing Company

catalent pharma solutions, llc,

1100 Enterprise Drive, Winchester,KY 40391 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

高血糖素鼻用粉雾剂 - NMPA 批准文号 | MedPath